1. The “new wave” of antidepressants: are these agents paradigm-shifters in treating major depression?
   B. Petrescu et al, 2023, Psihiatru.ro CrossRef
2. Supplemental low-dose esketamine to propofol versus propofol alone on perioperative characteristics in children undergoing surgery: a prospective randomized controlled trial
   Ding HAN et al, 2024, Minerva Anestesiologica CrossRef
3. Exploring Esketamine's Therapeutic Outcomes as an FDA-Designated Breakthrough for Treatment-Resistant Depression and Major Depressive Disorder With Suicidal Intent: A Narrative Review
   Suneeta Kumari et al, 2024, Cureus CrossRef
4. Ketamine and Transcranial Magnetic Stimulation in an Adolescent with Treatment-Resistant Depression
   Aarti U. Jerath et al, 2023, Journal of Child and Adolescent Psychopharmacology CrossRef
5. Baseline characteristics of a European patient population with difficult-to-treat depression (RESTORE-LIFE) treated with adjunctive vagus nerve stimulation
   Koen Demyttenaere et al, 2024, Journal of Affective Disorders CrossRef
6. Nanosystems, Drug Molecule Functionalization and Intranasal Delivery: An Update on the Most Promising Strategies for Increasing the Therapeutic Efficacy of Antidepressant and Anxiolytic Drugs
   Jéssica L. Antunes et al, 2023, Pharmaceutics CrossRef
7. New Light on Prions: Putative Role of PrPc in Pathophysiology of Mood Disorders
   Adrian Andrzej Chrobak et al, 2024, International Journal of Molecular Sciences CrossRef
8. Illuminating the way: the role of bright light therapy in the treatment of depression
   Biljana Kosanovic Rajacic et al, 2023, Expert Review of Neurotherapeutics CrossRef
9. Impact of Adjunctive VNS on Drug Load, Depression Severity, and Number of Neuromodulatory Maintenance Treatments
   Erhan Kavakbasi et al, 2024, Brain Sciences CrossRef
10. Preclinical models of treatment-resistant depression: challenges and perspectives
    Magdalena Kolasa et al, 2023, Pharmacological Reports CrossRef
11. Overcoming treatment gaps in the management of depression with non-pharmacological adjunctive strategies
    György Purebl et al, 2023, Frontiers in Psychiatry CrossRef
12. Esketamine Inhibits Cocaine-Seeking Behaviour Subsequent to Various Abstinence Conditions in Rats
    Karolina Wydra et al, 2023, Biomolecules CrossRef
13. Effect of single intravenous injection of esketamine on postpartum depression after labor analgesia and potential mechanisms: a randomized, double-blinded controlled trial
    Bin Ling et al, 2023, BMC Pharmacology and Toxicology CrossRef
14. Ketamine and Nitrous Oxide
    Alvin M. Janski et al, 2024, Reference Module in Neuroscience and Biobehavioral Psychology CrossRef
15. Therapeutic management of atypical antipsychotic‑related metabolic dysfunctions using GLP‑1 receptor agonists: A systematic review
    Octavian Vasiliu, 2023, Experimental and Therapeutic Medicine CrossRef
16. The Psychiatric, Psychological, and Psychotherapeutic Approach to Erectile Dysfunction – Between Good Practices and Clinical Challenges
    null null et al, 2024, Romanian Journal of Military Medicine CrossRef